Medical Marijuana, Inc. Subsidiary Kannaway Launches in Hong Kong


2021-09-03 10:00:13 CFN Media Group


SAN DIEGO, CA, Sept. 01, 2021 — via NewMediaWire — Medical Marijuana, Inc. , the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company’s subsidiary Kannaway® has launched its operations in Hong Kong. ​​”Our first Asian expansion has been a fantastic success in Japan and we now look forward to bringing our high-quality cannabidiol (CBD) products to Hong Kong as well,” Kannaway® CEO Blake Schroeder said. “Hemp has a long history in the region and, according to MJBizDaily, China is the world’s largest hemp producer. Now, with the global popularity of CBD on the rise, we’re seeing the citizens of Hong Kong who want to go back to their roots use hemp-derived CBD.” Kannaway® will be hosting regional events to educate current and potential Brand Ambassadors on the many potential wellness benefits and financial opportunities of hemp-derived CBD oil. About Kannaway® Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products. About Medical Marijuana, Inc. We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Neuropathix. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy. Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at or by visiting To see Medical Marijuana, Inc.’s corporate video, click here. FORWARD-LOOKING DISCLAIMER This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein. FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. LEGAL DISCLOSURE Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act. CONTACT: Public Relations Contact: Kathryn Brown Account Director CMW Media P. 858-264-6600 [email protected] Investor Relations Contact: P. (858) 283-4016 [email protected] This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
加州圣地亚哥,2021年9月1日(环球新闻社)--美国首家上市的大麻公司(OTC:MJNA)(“本公司”)今日宣布,该公司的附属公司Kannaway®已在港开展业务。该公司是美国首家上市的大麻公司,推出了全球首个大麻营养产品、品牌和供应链。 Kannaway®首席执行官Blake Schroeder说:“我们在日本的首次亚洲扩张取得了巨大成功,我们现在也期待着将我们的高质量大麻二酚(CBD)产品带到香港。”“大麻在该地区有着悠久的历史,据MJBizDaily报道,中国是世界上最大的大麻生产国。现在,随着CBD在全球的受欢迎程度不断上升,我们看到想回到自己根源的香港市民使用大麻衍生的CBD。“ Kannaway®将举办区域活动,教育现有和潜在的品牌大使关于大麻衍生CBD油的许多潜在健康好处和财务机会。 关于坎纳威·® Kannaway®是一家网络销售和营销公司,专门从事以大麻为基础的植物产品的销售和营销。Kannaway®目前在美国各地举办每周在线销售会议和会议,为渴望成为以大麻为基础的植物产品销售和营销成功领导者的销售专业人员提供独特的见解和机会。 关于医用大麻公司。 我们是一家®第一的公司。医用大麻公司(MJNA)是一家大麻公司,在非精神活性大麻领域有三个不同的业务部门:由坎纳威·®和亨普梅兹·®领导的全球大麻素营养品牌组合;从工业大麻中获取最高质量的合法非精神活性大麻产品的先驱;以及一个以大麻素为基础的临床研究和植物药物开发部门,由其制药投资公司和合作伙伴领导,包括Axim®生物技术公司和Neuropathix。医用大麻公司被美国消费者新闻与商业频道评为CBD顶级生产商。医用大麻公司也是第一家从巴西、墨西哥、阿根廷和巴拉圭政府获得《生物多样性公约》产品进口许可证的公司,是国际市场开发的领导者。该公司的旗舰产品Real Scientific大麻油已经在墨西哥和巴西的几个成功的临床研究中使用,以了解其安全性和有效性。 医用大麻公司的总部位于加利福尼亚州圣地亚哥,更多信息可在otcmarkets.com或访问。要查看医用大麻公司的企业视频,请点击此处。 前瞻性免责声明 本新闻稿可能包含1933年《证券法》第27A条和1934年《证券交易法》第21E条定义的某些前瞻性陈述和信息,并受这些条款所创建的安全港的约束。本材料包含关于预期未来事件和/或财务结果的陈述,这些陈述具有前瞻性,并受到风险和不确定性的影响。根据定义,这些前瞻性陈述涉及风险、不确定性和其他因素,这些因素可能导致医用大麻公司的实际结果、业绩或成就与本文所做的陈述存在重大差异。 美国食品药品监督管理局(FDA)披露 这些声明还没有经过食品和药物管理局的评估。本产品不用于诊断、治疗、治愈或预防任何疾病。 法律披露 医用大麻公司不销售或分销任何违反《美国受控物质法》的产品。 联系人: 公共关系联络人: 凯瑟琳·布朗 会计主管 CMW介质 第858-264-6600页 [电子邮件受保护] 投资者关系联系人: P.(858)283-4016 [电子邮件受保护] 本文由CFN Enterprises Inc.(OTCQB:CNFN)发表,该公司是CFN Media的所有者和运营商,CFN Media是行业领先的机构和数字金融媒体网络,致力于新兴的CBD和合法大麻行业。请致电+1(833)420-CNFN了解更多信息。